secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001615219-25-000078
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius amends Decoy merger: removes $2M threshold, changes conversion price adjustment
--------------------------------------------------------------------------------

- Fourth Amendment dated July 29, 2025 removes $2M threshold for 'subsequent financing' triggering conversion adjustment.
- Conversion price adjustment changes from weighted average to actual per share offering price in subsequent financings.
- One-year limitation on conversion ratio adjustments eliminated; adjustments apply until stockholder approval and Nasdaq listing standards met.
- Amendments intended to induce holders of Decoy convertible/non-convertible notes to consent and convert.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000078/0001615219-25-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000078/flks-20250729.htm
  HTML page:      https://secwatch.observer/filing/0001615219-25-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer